ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding ESSA Pharma Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 34.8M | 35.0M | +264.7K (+0.8%) |
| Value | $229.4M | $297.5M | +$68.0M (+29.6%) |
New holders (6)
Institutions that held ESSA Pharma Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 368,500 | $3.13M | 0.02% |
| Parkman Healthcare Partners LLC | 251,695 | $2.14M | 0.26% |
| Tucker Asset Management LLC | 16,097 | $136.7K | 0.03% |
| Millennium Management LLC | 14,052 | $119.3K | 0.00% |
| EntryPoint Capital, LLC | 4,420 | $37.5K | 0.03% |
| CIBC Private Wealth Group, LLC | 2,500 | $21.1K | 0.00% |
Sold out (4)
Institutions that held ESSA Pharma Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 24,234 | $160.0K |
| Privium Fund Management (UK) Ltd | 20,032 | $132.2K |
| Group One Trading, L.P. | 11,175 | $73.8K |
| Barclays PLC | 971 | $6.41K |